Santen Pharmaceutical Enhances Governance for Shareholder Value

Santen Pharmaceutical Co (JP:4536) has released an update.

Santen Pharmaceutical Co. has reinforced its corporate governance system to bolster corporate value and returns for shareholders, adopting a ‘Company with Board of Corporate Auditors’ system for robust oversight and decision-making. The company emphasizes the active involvement of Outside Directors and has established voluntary committees to enhance management transparency. Santen also ensures strategic shareholdings contribute to long-term business relations and corporate value enhancement, as demonstrated by the recent divestiture of four brands to optimize its balance sheet.

For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.